Dr. Shuren, who has served as the CDRH’s director for almost 15 years, announced he was stepping away from his position in a July 23 department-wide message. FDA Commissioner Robert Califf, MD, then announced Dr. Shuren’s retirement in a message to the entire organization later the same day.
Both announcements shared the appointment of Michelle Tarver, MD, PhD, as acting director of the CDRH, effective July 28. Dr. Tarver has been with the FDA since 2009 and currently serves as the CDRH deputy center director for transformation.
Dr. Shuren will assist in the search for his permanent successor as center director emeritus until his official exit from the FDA later this year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
